首页> 外文OA文献 >Analysis of conflicts of interest in pharmaceutical payments made to Food and Drug Administration physician advisers after dermatologic drug approval

【2h】

Analysis of conflicts of interest in pharmaceutical payments made to Food and Drug Administration physician advisers after dermatologic drug approval

机译：皮肤病药物批准后对食品和药物管理医师顾问的兴趣冲突分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Stephanie L. Kuschel; Claudia M. Ricotti; Cory A. Dunnick; Jeremy Hugh; Robert P. Dellavalle;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Analysis of conflicts of interest in pharmaceutical payments made to Food and Drug Administration physician advisers after dermatologic drug approval [J] . Kuschel Stephanie L., Ricotti Claudia M., Dunnick Cory A., Journal of the American Academy of Dermatology . 2019,第6期

机译：皮肤病药物批准后对食品和药物管理医生顾问的兴趣冲突分析
2. Financial Conflict of Interest and Academic Influence Among Experts Speaking on Behalf of the Pharmaceutical Industry at the US Food and Drug Administration's Oncologic Drugs Advisory Committee Meetings [J] . Lammers Austin, Edmiston Jonathan, Kaestner Victoria, Mayo Clinic Proceedings . 2017,第7期

机译：专家的财务利益和学术影响力代表美国食品和药物管理局的肿瘤药业咨询委员会会议发言
3. Do Conflicts of Interest Undermine FDA Approval Decisions?Diana Zuckerman says that the latest attempt by the US Food and Drug Administration to prevent conflicts of interest among its advisory committee members is still inadequate. [J] . Diana Zuckerman The regulatory affairs journal: Pharma . 2008,第9期

机译：利益冲突是否会破坏FDA的批准决定？戴安娜·扎克曼（Diana Zuckerman）表示，美国食品和药物管理局（FDA）在其咨询委员会成员之间防止利益冲突的最新尝试仍不充分。
4. Investigating the Food and Drug Administration (FDA) Biotherapeutics Review and Approval Process: A Scoping Review [C] . Samuel A. Bonet, Farzan Sasangohar, Mark Lawley Human Factors and Ergonomics Society annual meeting . 2018

机译：调查食品和药物管理局（FDA）生物治疗审查和审批过程：审查审查
5. Impact of Food and Drug Administration pediatric antidepressant use warnings on treatment of depression, physician specialty practice patterns, and pharmaceutical stock prices. [D] . Valluri, Satish C. 2009

机译：食品和药物管理局小儿抗抑郁药使用警告对抑郁症的治疗，医生的专业执业模式和药品价格的影响。
6. U.S. Food and Drug Administration: Review for the Emergency Physician of Approval Process and Limitations [O] . Nadia Zuabi, Bhavesh Patel, Mark I. Langdorf 2016

机译：美国食品药品监督管理局：审批批准过程和限制的急诊医师
7. Comparisons of Food and Drug Administration and European Medicines Agency Risk Management Implementation for Recent Pharmaceutical Approvals: Report of the International Society for Pharmacoeconomics and Outcomes Research Risk Benefit Management Working Group [O] . Lis Yvonne, Roberts Melissa H., Kamble Shital, 2012

机译：食品药品监督管理局与欧洲药品管理局最近的药品批准实施风险管理的比较：国际药物经济学和结果学会风险风险管理工作组的报告

Analysis of conflicts of interest in pharmaceutical payments made to Food and Drug Administration physician advisers after dermatologic drug approval

著录项

引文网络

相似文献

相关主题

期刊订阅